Viral vectors: A wide range of choices and high levels of service

Handbook of Experimental Pharmacology

Volumn 178, Issue , 2007, Pages 177-202

  Osten, P ^a,b   Grinevich, V ^a   Cetin, A ^a  

^a MAX PLANCK INSTITUTE FOR MEDICAL RESEARCH   (Germany)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Conditional gene expression; Conditional gene knock down; Gene delivery; Recombinant viral vectors

Indexed keywords

ADENO ASSOCIATED VIRUS; ADENOVIRUS; ANIMAL; GENE VECTOR; GENETICS; HERPES SIMPLEX VIRUS 1; RETROVIRUS; REVIEW; VIRUS;

ADENOVIRIDAE; ANIMALS; DEPENDOVIRUS; GENETIC VECTORS; HERPESVIRUS 1, HUMAN; RETROVIRIDAE; VIRUSES;

EID: 33846926100     PISSN: 01712004     EISSN: 18650325     Source Type: Book Series    
DOI: 10.1007/978-3-540-35109-2_8     Document Type: Review

References (105)

1. Apparailly F, Millet V, Noel D, Jacquet C, Sany J, Jorgensen C (2002) Tetracycline-inducible interleukin-10 gene transfer mediated by an adeno-associated virus: application to experimental arthritis. Hum Gene Ther 13:1179-1188
2. Auricchio A,GaoGP,YuQC, Raper S, RiveraVM,ClacksonT,WilsonJM (2002a) Constitutive and regulated expression of processed insulin following in vivo hepatic gene transfer. Gene Ther 9:963-971
3. Auricchio A, Rivera VM, Clackson T, O'Connor EE, Maguire AM, Tolentino MJ, Bennett J,Wilson JM (2002b) Pharmacological regulation of protein expression fromadenoassociated viral vectors in the eye. Mol Ther 6:238-242
4. Bantounas I, Phylactou LA,Uney JB (2004) RNAinterference and the use of small interfering RNA to study gene function in mammalian systems. J Mol Endocrinol 33:545-557
5. Baskar JF, Smith PP, Nilaver G, Jupp RA, Hoffmann S, Peffer NJ, Tenney DJ, Colberg-Poley AM, Ghazal P, Nelson JA (1996) The enhancer domain of the human cytomegalovirusmajor immediate-early promoter determines cell type-specific expression in transgenic mice. J Virol 70:3207-3214
6. Bohl D, Salvetti A, Moullier P, Heard JM (1998) Control of erythropoietin delivery by doxycycline in mice after intramuscular injection of adeno-associated vector. Blood 92:1512-1517
7. Bowers WJ, Olschowka JA, Federoff HJ (2003) Immune responses to replication-defective HSV-1 type vectorswithin the CNS: implications for gene therapy. Gene Ther 10:941-945
8. Büchen-Osmond C (2001) The Universal Virus Database of the International Committee on Taxonomy of Viruses (ICTVdB) : http://www.ncbi.nlm. nih.gov/ICTVdb/index.htm . Cited 15 June 2006
9. Burns JC, Friedmann T, DrieverW, Burrascano M, Yee JK (1993) Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc Natl Acad Sci U S A 90:8033-8037
10. Chao H, Liu Y, Rabinowitz J, Li C, Samulski RJ, Walsh CE (2000) Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors. Mol Ther 2:619-623
11. Chen Y, Stamatoyannopoulos G, Song CZ (2003) Down-regulation of CXCR4 by inducible small interfering RNA inhibits breast cancer cell invasion in vitro. Cancer Res 63:4801-4804
12. Chenuaud P, Larcher T, Rabinowitz JE, Provost N, Joussemet B, Bujard H, Samulski RJ, Favre D, Moullier P (2004) Optimal design of a single recombinant adeno-associated virus derived from serotypes 1 and 2 to achieve more tightly regulated transgene expression from nonhuman primate muscle. Mol Ther 9:410-418
13. Clark KR, Liu X, McGrath JP, Johnson PR (1999) Highly purified recombinant adenoassociatedvirus vectors are biologically active and free of detectable helper andwild-type viruses. Hum Gene Ther 10:1031-1039
14. Davidson BL,Harper SQ (2005) Viral delivery of recombinant short hairpin RNAs.Methods Enzymol 392:145-173
15. Davidson BL, Stein CS, Heth JA, Martins I, Kotin RM, Derksen TA, Zabner J, Ghodsi A, Chiorini JA (2000) Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system. Proc Natl Acad Sci U S A 97:3428-3432
16. Di Pasquale G, Davidson BL, Stein CS, Martins I, Scudiero D, Monks A, Chiorini JA (2003) Identification of PDGFR as a receptor for AAV-5 transduction. Nat Med 9:1306-1312
17. DittgenT,Nimmerjahn A,Komai S, LicznerskiP,Waters J,MargrieTW,Helmchen F,DenkW, Brecht M, Osten P (2004) Lentivirus-based genetic manipulations of cortical neurons and their optical and electrophysiological monitoring in vivo. Proc Natl Acad Sci U S A 101:18206-18211
18. Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, Trono D, Naldini L (1998) A thirdgeneration lentivirus vector with a conditional packaging system. J Virol 72:8463-8471
19. Fitzsimons HL, McKenzie JM, During MJ (2001) Insulators coupled to a minimal bidirectional tet cassette for tight regulation of rAAV-mediated gene transfer in the mammalian brain. Gene Ther 8:1675-1681
20. Fotaki ME, Pink JR, Mous J (1997) Tetracycline-responsive gene expression in mouse brain after amplicon-mediated gene transfer. Gene Ther 4:901-908
21. FrankelAD,Young JA (1998) HIV-1: fifteen proteins and anRNA.AnnuRevBiochem 67:1-25
22. Fussenegger M, Morris RP, Fux C, Rimann M, von Stockar B, Thompson CJ, Bailey JE (2000) Streptogramin-based gene regulation systems for mammalian cells. Nat Biotechnol 18:1203-1208
23. Gafni Y, Pelled G, Zilberman Y, Turgeman G, Apparailly F, Yotvat H, Galun E, Gazit Z, Jorgensen C, Gazit D (2004) Gene therapy platform for bone regeneration using an exogenously regulated, AAV-2-based gene expression system. Mol Ther 9:587-595
24. Gaggar A, Shayakhmetov DM, Lieber A (2003) CD46 is a cellular receptor for group B adenoviruses. Nat Med 9:1408-1412
25. GaoGP,AlviraMR,Wang L, CalcedoR, Johnston J,Wilson JM (2002) Novel adeno-associated viruses fromrhesusmonkeysasvectors forhumangene therapy.ProcNatlAcadSciUSA 99:11854-11859
26. Geller AI, Breakefield XO (1988) A defective HSV-1 vector expresses Escherichia coli betagalactosidase in cultured peripheral neurons. Science 241:1667-1669
27. Gilbert R, Dudley RW, Liu AB, Petrof BJ, Nalbantoglu J, Karpati G (2003) Prolonged dystrophin expression and functional correction of mdx mouse muscle following gene transfer with a helper-dependent (gutted) adenovirus-encoding murine dystrophin. Hum Mol Genet 12:1287-1299
28. Goins WF, Lee KA, Cavalcoli JD, O'Malley ME, DeKosky ST, Fink DJ, Glorioso JC (1999) Herpes simplex virus type 1 vector-mediated expression of nerve growth factor protects dorsal root ganglion neurons from peroxide toxicity. J Virol 73:519-532
29. Gossen M, Bujard H (1992) Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci U S A 89:5547-5551
30. Gossen M, Freundlieb S, Bender G, Muller G, Hillen W, Bujard H (1995) Transcriptional activation by tetracyclines in mammalian cells. Science 268:1766-1769
31. Grimm D, Kay MA (2003) From virus evolution to vector revolution: use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy. Curr Gene Ther 3:281-304
32. Grimm D, Kern A, Rittner K, Kleinschmidt JA (1998) Novel tools for production and purification of recombinant adeno-associated virus vectors. Hum Gene Ther 9:2745-2760
33. Grimm D, Kay MA, Kleinschmidt JA (2003) Helper virus-free, optically controllable, and two-plasmid-based production of adeno-associated virus vectors of serotypes 1 to 6. Mol Ther 7:839-850
34. Haberman RP, McCown TJ, Samulski RJ (1998) Inducible long-term gene expression in brain with adeno-associated virus gene transfer. Gene Ther 5:1604-1611
35. Halbert CL, Allen JM, Miller AD (2001) Adeno-associated virus type 6 (AAV6) vectors mediate efficient transduction of airway epithelial cells inmouse lungs compared to that of AAV2 vectors. J Virol 75:6615-6624
36. Hauck B, Chen L, XiaoW (2003) Generation and characterization of chimeric recombinant AAV vectors. Mol Ther 7:419-425
37. Hosono T, Mizuguchi H, Katayama K, Xu ZL, Sakurai F, Ishii-Watabe A, Kawabata K, Yamaguchi T, Nakagawa S, Mayumi T, Hayakawa T (2004) Adenovirus vector-mediated doxycycline-inducible RNA interference. Hum Gene Ther 15:813-819
38. Jiang L, Rampalli S, George D, Press C, Bremer EG, O'Gorman MR, Bohn MC (2004) Tight regulation from a single tet-off rAAV vector as demonstrated by flow cytometry and quantitative, real-time PCR. Gene Ther 11:1057-1067
39. Kafri T, van Praag H, Gage FH, Verma IM (2000) Lentiviral vectors: regulated gene expression. Mol Ther 1:516-521
40. Kim IH, Jozkowicz A, Piedra PA, Oka K, Chan L (2001) Lifetime correction of genetic deficiency in mice with a single injection of helper-dependent adenoviral vector. Proc Natl Acad Sci U S A 98:13282-13287
41. Lois C, Hong EJ, Pease S, Brown EJ, Baltimore D (2002) Germline transmission and tissuespecific expression of transgenes delivered by lentiviral vectors. Science 295:868-872
42. Markusic D, Oude-Elferink R, Das AT, Berkhout B, Seppen J (2005) Comparison of single regulated lentiviral vectors with rtTA expression driven by an autoregulatory loop or a constitutive promoter. Nucleic Acids Res 33:e63
43. Martin KR, Klein RL, Quigley HA (2002) Gene delivery to the eye using adeno-associated viral vectors. Methods 28:267-275
44. Matsukura S, Jones PA, Takai D (2003) Establishment of conditional vectors for hairpin siRNA knockdowns. Nucleic Acids Res 31:e77
45. Matsushita T, Elliger S, Elliger C, Podsakoff G, Villarreal L, Kurtzman GJ, Iwaki Y, Colosi P (1998) Adeno-associated virus vectors can be efficiently produced without helper virus. Gene Ther 5:938-945
46. Mazarakis ND, Azzouz M, Rohll JB, Ellard FM, Wilkes FJ, Olsen AL, Carter EE, Barber RD, Baban DF, Kingsman SM, Kingsman AJ, O'Malley K, Mitrophanous KA (2001) Rabies virus glycoprotein pseudotyping of lentiviral vectors enables retrograde axonal transport and access to the nervous system after peripheral delivery.HumMolGenet 10:2109-2121
47. McCarty DM, FuH,Monahan PE, Toulson CE, Naik P, Samulski RJ (2003) Adeno-associated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in vivo. Gene Ther 10:2112-2118
48. McCarty DM, Young SMJr, Samulski RJ (2004) Integration of adeno-associated virus (AAV) and recombinant AAV vectors. Annu Rev Genet 38:819-845
49. McConnell MJ, Imperiale MJ (2004) Biology of adenovirus and its use as a vector for gene therapy. Hum Gene Ther 15:1022-1033
50. Meister G, Tuschl T (2004) Mechanisms of gene silencing by double-stranded RNA. Nature 431:343-349
51. Mitrophanous K, Yoon S, Rohll J, Patil D, Wilkes F, Kim V, Kingsman S, Kingsman A, Mazarakis N (1999) Stable gene transfer to the nervous system using a non-primate lentiviral vector. Gene Ther 6:1808-1818
52. Miyagishi M, Taira K (2002) Development and application of siRNA expression vector. Nucleic Acids Res Suppl:113-114
53. Miyoshi H, Blomer U, Takahashi M, Gage FH, Verma IM (1998) Development of a selfinactivating lentivirus vector. J Virol 72:8150-8157
54. Mizuguchi H, Hayakawa T (2004) Targeted adenovirus vectors. Hum Gene Ther 15:1034-1044
55. Muruve DA (2004) The innate immune response to adenovirus vectors. Hum Gene Ther 15:1157-1166
56. Nakai H, Storm TA, Kay MA (2000) Increasing the size of rAAV-mediated expression cassettes in vivo by intermolecular joining of two complementary vectors. Nat Biotechnol 18:527-532
57. Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage FH, Verma IM, Trono D (1996) In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272:263-267
58. Ohkawa J, Taira K (2000) Control of the functional activity of an antisense RNA by a tetracycline-responsive derivative of the human U6 snRNA promoter. HumGene Ther 11:577-585
59. Pages JC, Bru T (2004) Toolbox for retrovectorologists. J Gene Med 6 [Suppl 1]: S67-S82
60. PalmerD, Ng P (2003) Improved systemfor helper-dependent adenoviral vector production. Mol Ther 8:846-852
61. Palmer DJ, Ng P (2005) Helper-dependent adenoviral vectors for gene therapy. Hum Gene Ther 16:1-16
62. Paterna JC, Büeler H (2002) Recombinant adeno-associated virus vector design and gene expression in the mammalian brain. Methods 28:208-218
63. Pfeifer A (2004) Lentiviral transgenesis. Transgenic Res 13:513-522
64. Poeschla EM (2003) Non-primate lentiviral vectors. Curr Opin Mol Ther 5:529-540
65. Poeschla EM,Wong-Staal F, Looney DJ (1998) Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors. Nat Med 4:354-357
66. Pollock R, Clackson T (2002) Dimerizer-regulated gene expression. Curr Opin Biotechnol 13:459-467
67. PollockR, IssnerR,Zoller K,Natesan S, RiveraVM,ClacksonT (2000) Delivery of a stringent dimerizer-regulated gene expression system in a single retroviral vector. Proc Natl Acad Sci U S A 97:13221-13226
68. Rabinowitz JE, Rolling F, Li C, Conrath H, Xiao W, Xiao X, Samulski RJ (2002) Crosspackaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity. J Virol 76:791-801
69. Regulier E, Trottier Y, Perrin V, Aebischer P, Deglon N (2003) Early and reversible neuropathology induced by tetracycline-regulated lentiviral overexpression ofmutant huntingtin in rat striatum. Hum Mol Genet 12:2827-2836
70. Rivera VM, Clackson T, Natesan S, Pollock R, Amara JF, Keenan T, Magari SR, Phillips T, Courage NL, Cerasoli F Jr, Holt DA, Gilman M (1996) A humanized system for pharmacologic control of gene expression. Nat Med 2:1028-1032
71. Rivera VM,Ye X,Courage NL, Sachar J,Cerasoli F Jr,Wilson JM, GilmanM (1999) Long-term regulated expression of growth hormone in mice after intramuscular gene transfer. Proc Natl Acad Sci U S A 96:8657-8662
72. Saeki Y, Ichikawa T, Saeki A, Chiocca EA, Tobler K, Ackermann M, Breakefield XO, Fraefel C (1998) Herpes simplex virus type 1 DNA amplified as bacterial artificial chromosome in Escherichia coli: rescue of replication-competent virus progeny and packaging of amplicon vectors. Hum Gene Ther 9:2787-2794
73. Saeki Y, Fraefel C, Ichikawa T, Breakefield XO, Chiocca EA (2001) Improved helper virus-free packaging system for HSV amplicon vectors using an ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome. Mol Ther 3:591-601
74. Salucci V, Scarito A, Aurisicchio L, Lamartina S, Nicolaus G, Giampaoli S, Gonzalez-Paz O, Toniatti C, Bujard H, Hillen W, Ciliberto G, Palombo F (2002) Tight control of gene expression by a helper-dependent adenovirus vector carrying the rtTA2 (s)-M2 tetracycline transactivator and repressor system. Gene Ther 9:1415-1421
75. Samaniego LA, Neiderhiser L, DeLuca NA (1998) Persistence and expression of the herpes simplex virus genome in the absence of immediate-early proteins. J Virol 72:3307-3320
76. Schiedner G,Morral N, Parks RJ,Wu Y, Koopmans SC, Langston C, Graham FL, Beaudet AL, Kochanek S (1998) GenomicDNAtransferwith a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity. Nat Genet 18:180-183
77. Shah AC, Benos D, Gillespie GY, Markert JM (2003) Oncolytic viruses: clinical applications as vectors for the treatment of malignant gliomas. J Neurooncol 65:203-226
78. ShevtsovaZ,Malik JM,MichelU, BahrM,Kugler S (2005) Promoters andserotypes: targeting of adeno-associated virus vectors for gene transfer in the rat central nervous system in vitro and in vivo. Exp Physiol 90:53-59
79. Spaete RR, FrenkelN (1982) The herpes simplex virus amplicon: a new eucaryotic defectivevirus cloning-amplifying vector. Cell 30:295-304
80. Stavropoulos TA, Strathdee CA (1998) An enhanced packaging system for helper-dependent herpes simplex virus vectors. J Virol 72:7137-7143
81. Summerford C, Samulski RJ (1998) Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J Virol 72:1438-1445
82. Sun L, Li J, Xiao X (2000) Overcoming adeno-associated virus vector size limitation through viral DNA heterodimerization. Nat Med 6:599-602
83. TenenbaumL, ChtartoA, Lehtonen E,Velu T, Brotchi J, LevivierM (2004) RecombinantAAVmediated gene delivery to the central nervous system. J GeneMed 6 [Suppl 1]:S212-S222
84. Tuschl T (2002) Expanding small RNA interference. Nat Biotechnol 20:446-448
85. Unsinger J, Kroger A, Hauser H, Wirth D (2001) Retroviral vectors for the transduction of autoregulated, bidirectional expression cassettes. Mol Ther 4:484-489
86. van deWetering M,Oving I,MuncanV, Pon FongMT, BrantjesH, van LeenenD,Holstege FC, Brummelkamp TR, Agami R, Clevers H (2003) Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector. EMBO Rep 4:609-615
87. Vigna E, Cavalieri S, Ailles L, Geuna M, Loew R, Bujard H, Naldini L (2002) Robust and efficient regulation of transgene expression in vivo by improved tetracycline-dependent lentiviral vectors. Mol Ther 5:252-261
88. Vigna E, Amendola M, Benedicenti F, Simmons AD, Follenzi A, Naldini L (2005) Efficient Tet-dependent expression of human factor IX in vivo by a new self-regulating lentiviral vector. Mol Ther 11:763-775
89. Wade-Martins R, Smith ER, Tyminski E, Chiocca EA, Saeki Y (2001) An infectious transfer and expression systemfor genomic DNA loci in human andmouse cells. Nat Biotechnol 19:1067-1070
90. Wang S, Petravicz J, Breakefield XO (2003) Single HSV-amplicon vector mediates druginduced gene expression via dimerizer system. Mol Ther 7:790-800
91. Wang Z, Ma HI, Li J, Sun L, Zhang J, Xiao X (2003) Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo. Gene Ther 10:2105-2111
92. Wang Z, Zhu T, Qiao C, Zhou L, Wang B, Zhang J, Chen C, Li J, Xiao X (2005) Adenoassociated virus serotype 8 efficiently delivers genes tomuscle and heart. Nat Biotechnol 23:321-328
93. WeberW, FusseneggerM (2004) Approaches for trigger-inducible viral transgene regulation in gene-based tissue engineering. Curr Opin Biotechnol 15:383-391
94. Wiznerowicz M, TronoD (2003) Conditional suppression of cellular genes: lentivirus vectormediated drug-inducible RNA interference. J Virol 77:8957-8961
95. Wiznerowicz M, Trono D (2005) Harnessing HIV for therapy, basic research and biotechnology. Trends Biotechnol 23:42-47
96. Xiao X, Li J, Samulski RJ (1998) Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J Virol 72:2224-2232
97. Yan Z, Zhang Y, Duan D, Engelhardt JF (2000) Trans-splicing vectors expand the utility of adeno-associated virus for gene therapy. Proc Natl Acad Sci U S A 97:6716-6721
98. Ye X, RiveraVM,ZoltickP,Cerasoli F Jr, SchnellMA, Gao G,Hughes JV, Gilman M,WilsonJM (1999) Regulated delivery of therapeutic proteins after in vivo somatic cell gene transfer. Science 283:88-91
99. Yee JK, Friedmann T, Burns JC (1994) Generation of high-titer pseudotyped retroviral vectors with very broad host range. Methods Cell Biol 43:99-112
100. Yu SF, von Ruden T, Kantoff PW, Garber C, SeibergM, RutherU,AndersonWF, Wagner EF, Gilboa E (1986) Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells. Proc Natl Acad Sci U S A 83:3194-3198
101. Zolotukhin S (2005) Production of recombinant adeno-associated virus vectors. Hum Gene Ther 16:551-557
102. Zolotukhin S, Byrne BJ, Mason E, Zolotukhin I, Potter M, Chesnut K, Summerford C, Samulski RJ,MuzyczkaN (1999) Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Ther 6:973-985
103. Zou L, Yuan X, Zhou H, Lu H, Yang K (2001) Helper-dependent adenoviral vector-mediated gene transfer in aged rat brain. Hum Gene Ther 12:181-191
104. Zufferey R, Nagy D, Mandel RJ, Naldini L, Trono D (1997) Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat Biotechnol 15:871-875
105. Zufferey R, Dull T, Mandel RJ, Bukovsky A, Quiroz D, Naldini L, Trono D (1998) Selfinactivating lentivirus vector for safe and efficient in vivo gene delivery. J Virol 72:9873-9880